Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Neoplasm"" wg kryterium: Temat


Tytuł :
NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
Autorzy :
He W; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.; Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Cheng F; Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China.; Department of Nephrology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Zheng B; Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Wang J; Department of Urology, Shandong Provincial ENT Hospital Affiliated to Shandong University, Jinan, Shandong, China.
Zhao G; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Yao Z; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhang T; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.; Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Pokaż więcej
Źródło :
Aging [Aging (Albany NY)] 2021 May 24; Vol. 13 (10), pp. 14015-14038. Date of Electronic Publication: 2021 May 24.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Signal Transduction*/drug effects
Basic Helix-Loop-Helix Transcription Factors/*metabolism
Biomarkers, Tumor/*metabolism
Carcinoma, Renal Cell/*metabolism
Kidney Neoplasms/*metabolism
Neoplasm Proteins/*metabolism
Neoplastic Stem Cells/*pathology
Sorafenib/*pharmacology
Aged ; Animals ; Apoptosis/drug effects ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/pathology ; Cell Cycle Checkpoints/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Disease-Free Survival ; Down-Regulation/drug effects ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Kidney Neoplasms/genetics ; Kidney Neoplasms/pathology ; Male ; Mice, Inbred BALB C ; Middle Aged ; Multivariate Analysis ; Neoplasm Invasiveness ; Neoplasm Proteins/genetics ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; PTEN Phosphohydrolase/metabolism ; Prognosis ; Proportional Hazards Models ; Proto-Oncogene Proteins c-akt/metabolism ; TOR Serine-Threonine Kinases/metabolism ; Up-Regulation/drug effects
Czasopismo naukowe
Tytuł :
A comprehensive review on time-tested anticancer drug doxorubicin.
Autorzy :
Sritharan S; Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, 603 203 Chengalpattu District, Tamil Nadu, India.
Sivalingam N; Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur, 603 203 Chengalpattu District, Tamil Nadu, India. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Aug 01; Vol. 278, pp. 119527. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Resistance, Neoplasm*
Antineoplastic Agents/*pharmacology
Doxorubicin/*pharmacology
Neoplasms/*drug therapy
Antigens, Neoplasm/metabolism ; Apoptosis/drug effects ; Calcium/metabolism ; Cell Line, Tumor ; DNA Damage/drug effects ; Dendritic Cells/cytology ; Drug Synergism ; Epigenomics ; Hemostasis ; Humans ; MicroRNAs/metabolism ; Neoplasm Recurrence, Local ; Neoplasms/metabolism ; Reactive Oxygen Species ; Signal Transduction ; Topoisomerase II Inhibitors/pharmacology
Czasopismo naukowe
Tytuł :
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.
Autorzy :
Park JH; Department of Hemato-Oncology, Konkuk Medical Center, University of Konkuk College of Medicine, Seoul, Republic of Korea.
You GL; Department of Biostatistics, College of Medicine, Korea University, Seoul, Republic of Korea.
Ahn MJ; Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim SW; Department of Medical Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hong MH; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Han JY; Center for Lung Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
Ock CY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Oh IJ; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Gwangju, Republic of Korea.
Lee SY; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Kim CH; Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Republic of Korea.
Min YJ; Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Choi YH; Dongnam Institute of Radiological and Medical Sciences, Busan, Republic of Korea.
Ryu JS; Department of Internal Medicdine, Inha University Hospital, Incheon, Republic of Korea.
Park SH; Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.
Ahn HK; Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
Shim BY; Department of Medical Oncology, St. Vincent Hospital, The Catholic University of Korea, Suwon, Republic of Korea.
Lee KH; Division of Medical Oncology, Department of Medicine, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
Lee SY; Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Kim JS; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Yi J; Health Insurance Review and Assessment, Pharmaceutical Benefits Management Division Department, Wonju, Korea.
Choi SK; Health Insurance Review and Assessment, Pharmaceutical Benefits Management Division Department, Wonju, Korea.
An H; Department of Biostatistics, College of Medicine, Korea University, Seoul, Republic of Korea.
Kang JH; Department of Medical Oncology, Seoul St. Mary's Hospital, The Catholic University, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Aug; Vol. 147 (8), pp. 2459-2469. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Resistance, Neoplasm*/drug effects
Antineoplastic Agents, Immunological/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Cisplatin/*therapeutic use
Lung Neoplasms/*drug therapy
Programmed Cell Death 1 Receptor/*immunology
Aged ; Aged, 80 and over ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/metabolism ; Nivolumab/therapeutic use ; Prognosis ; Republic of Korea/epidemiology ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Regulation of bone metastasis and metastasis suppressors by non-coding RNAs in breast cancer.
Autorzy :
Sanjeev G; Department of Biotechnology, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, 603 103, Tamil Nadu, India.
Pranavkrishna S; Department of Biotechnology, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, 603 103, Tamil Nadu, India.
Akshaya RL; Department of Biotechnology, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, 603 103, Tamil Nadu, India.
Rohini M; Department of Biotechnology, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, 603 103, Tamil Nadu, India.
Selvamurugan N; Department of Biotechnology, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, 603 103, Tamil Nadu, India. Electronic address: .
Pokaż więcej
Źródło :
Biochimie [Biochimie] 2021 Aug; Vol. 187, pp. 14-24. Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bone Neoplasms*/genetics
Bone Neoplasms*/metabolism
Bone Neoplasms*/pathology
Bone Neoplasms*/secondary
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Breast Neoplasms*/pathology
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
RNA, Neoplasm*/genetics
RNA, Neoplasm*/metabolism
RNA, Untranslated*/genetics
RNA, Untranslated*/metabolism
Female ; Humans ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł :
PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance.
Autorzy :
He Y; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Huang C; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.
Cai K; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.
Liu P; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Chen X; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Xu YI; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.
Ming Z; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.; Department of Biochemistry and Molecular Biology, School of Life Sciences, Central South University, Changsha 410008, China.
Liu Q; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Xie Q; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Xia X; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.; Department of Biochemistry and Molecular Biology, School of Life Sciences, Central South University, Changsha 410008, China.
Sun Y; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Luo J; Department of General Surgery and the Hunan Provincial Key Lab of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha 410008, China.
Wei R; Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Pokaż więcej
Źródło :
Acta biochimica et biophysica Sinica [Acta Biochim Biophys Sin (Shanghai)] 2021 Jul 05; Vol. 53 (7), pp. 893-902.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Movement*/drug effects
Cell Movement*/radiation effects
Cell Proliferation*/drug effects
Cell Proliferation*/radiation effects
Chemoradiotherapy*
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/radiation effects
Radiation Tolerance*/drug effects
Radiation Tolerance*/radiation effects
Tongue Neoplasms*/genetics
Tongue Neoplasms*/metabolism
Tongue Neoplasms*/pathology
Tongue Neoplasms*/therapy
Cisplatin/*pharmacology
DNA Repair Enzymes/*metabolism
Nuclear Proteins/*metabolism
RNA Splicing Factors/*metabolism
Animals ; Cell Line, Tumor ; DNA Repair Enzymes/genetics ; Female ; Humans ; Male ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Middle Aged ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism ; Nuclear Proteins/genetics ; RNA Splicing Factors/genetics ; Radiation, Ionizing ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer.
Autorzy :
Qiu J; Center of Clinical Laboratory, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou, 215000, Jiangsu, China.
Yang B; Department of Imaging, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, No. 26 Shengli Street, Jiangan District, Wuhan, 430014, Hubei, China. .
Pokaż więcej
Źródło :
Molecular and cellular biochemistry [Mol Cell Biochem] 2021 Jan; Vol. 476 (1), pp. 1-10. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Neoplasm Metastasis*
Antigens, Neoplasm/*physiology
Neoplasm Proteins/*physiology
Prostatic Neoplasms/*metabolism
Proto-Oncogene Proteins c-myc/*metabolism
Animals ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Fructose-Bisphosphatase/metabolism ; Humans ; Male ; Melanoma/pathology ; Mice ; Mice, Nude ; Neoplasm Invasiveness ; Neoplasm Transplantation ; Transcriptional Activation ; Up-Regulation
Czasopismo naukowe
Tytuł :
Concordance Between 21-Gene Recurrence Scores in Multifocal or Multicentric Breast Carcinomas Differs by Age and Histologic Subtype.
Autorzy :
Pawloski KR; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wen HY; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Tadros AB; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abbate K; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Morrow M; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
El-Tamer M; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. .
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Aug; Vol. 28 (8), pp. 4256-4262. Date of Electronic Publication: 2021 Jan 03.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Biomarkers, Tumor/genetics ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Prognosis ; Receptor, ErbB-2/genetics
Czasopismo naukowe
Tytuł :
The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features.
Autorzy :
Erdur E; Department of Internal Medicine, Division of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Yildirim OA; Department of Internal Medicine, Division of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Poyraz K; Department of Radiation Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Aslan F; Medical Oncology Department, Medical Park Ankara Hospital, Ankara, Turkey.
Yıldız F; Medical Oncology, Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
Kömek H; Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Pokaż więcej
Źródło :
Postgraduate medicine [Postgrad Med] 2021 Aug; Vol. 133 (6), pp. 694-700. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Journal Article
MeSH Terms :
Colonic Neoplasms*/blood
Colonic Neoplasms*/pathology
Inflammation*/blood
Inflammation*/pathology
Lymphocytes*
Neoplasm Recurrence, Local*/blood
Neoplasm Recurrence, Local*/diagnosis
Neutrophils*
Leukocyte Count/*methods
C-Reactive Protein/analysis ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Risk Assessment/methods ; Risk Factors ; Serum Albumin/analysis
Czasopismo naukowe
Tytuł :
Endoscopic resection of T1 colorectal cancer before surgery does not affect recurrence.
Autorzy :
Yang D; Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA.
Draganov PV; Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, Florida, USA.
Pokaż więcej
Źródło :
Gastrointestinal endoscopy [Gastrointest Endosc] 2021 Aug; Vol. 94 (2), pp. 405-407. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colorectal Neoplasms*/pathology
Colorectal Neoplasms*/surgery
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Endoscopy ; Humans ; Neoplasm Staging
Opinia redakcyjna
Tytuł :
Grading of Multifocal Prostate Cancer Cases in which the Largest Volume and the Highest Grade Do Not Coincide within One Lesion.
Autorzy :
Matsumoto K; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Omura M; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Takeda T; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Kosaka T; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Hashiguchi A; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Takamatsu K; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Yasumizu Y; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Tanaka N; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Morita S; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Mizuno R; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Asanuma H; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Oya M; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Aug; Vol. 206 (2), pp. 338-345. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Grading*
Prostatic Neoplasms/*pathology
Adult ; Aged ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prostatectomy ; Prostatic Neoplasms/surgery ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Targeting the Highly Expressed microRNA miR-146b with CRISPR/Cas9n Gene Editing System in Thyroid Cancer.
Autorzy :
Santa-Inez DC; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
Fuziwara CS; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
Saito KC; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
Kimura ET; Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 27; Vol. 22 (15). Date of Electronic Publication: 2021 Jul 27.
Typ publikacji :
Journal Article
MeSH Terms :
CRISPR-Cas Systems*
Gene Editing*
Gene Targeting*
MicroRNAs*/biosynthesis
MicroRNAs*/genetics
RNA, Neoplasm*/biosynthesis
RNA, Neoplasm*/genetics
Thyroid Carcinoma, Anaplastic*/genetics
Thyroid Carcinoma, Anaplastic*/metabolism
Thyroid Carcinoma, Anaplastic*/pathology
Thyroid Neoplasms*/genetics
Thyroid Neoplasms*/metabolism
Thyroid Neoplasms*/pathology
Animals ; Cell Line ; Cell Movement/genetics ; Cell Survival/genetics ; Heterografts ; Humans ; Mice ; Neoplasm Transplantation
Czasopismo naukowe
Tytuł :
Predictors of recurrence in patients with high-grade cervical intraepithelial neoplasia after cervical conization.
Autorzy :
Ge Y; Department of Gynecology, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou No.1 People's Hospital, Xuzhou, P.R. China.
Liu Y; Department of Gynecology, Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University, Xuzhou No.1 People's Hospital, Xuzhou, P.R. China.
Cheng Y; Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, P.R. China.
Liu Y; Department of Gynecology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, P.R. China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jul 09; Vol. 100 (27), pp. e26359.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Staging*
Cervical Intraepithelial Neoplasia/*diagnosis
Conization/*methods
Electrosurgery/*methods
Neoplasm Recurrence, Local/*epidemiology
Uterine Cervical Neoplasms/*diagnosis
Adult ; Cervical Intraepithelial Neoplasia/surgery ; Female ; Humans ; Margins of Excision ; Neoplasm Recurrence, Local/diagnosis ; Retrospective Studies ; Risk Factors ; Uterine Cervical Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Results After Conservative Surgery of Stage II/III Serous Borderline Ovarian Tumors.
Autorzy :
Gouy S; Department of Gynaecologic Surgery, Institut Gustave-Roussy, Villejuif, France.
Maria S; Department of Gynaecologic Surgery, Institut Gustave-Roussy, Villejuif, France.
Faron M; Department of Gynaecologic Surgery, Institut Gustave-Roussy, Villejuif, France.
Maulard A; Department of Gynaecologic Surgery, Institut Gustave-Roussy, Villejuif, France.
Pautier P; Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France.
Leary A; Department of Medical Oncology, Institut Gustave-Roussy, Villejuif, France.
Chargari C; Department of Radiation Oncology, Institut Gustave-Roussy, Villejuif, France.
Genestie C; Department of Pathology, Institut Gustave-Roussy, Villejuif, France.
Morice P; Department of Gynaecologic Surgery, Institut Gustave-Roussy, Villejuif, France. .; Paris-Sud University, Paris, France. .
Pokaż więcej
Źródło :
Annals of surgical oncology [Ann Surg Oncol] 2021 Jul; Vol. 28 (7), pp. 3597-3604. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Ovarian Neoplasms*/pathology
Ovarian Neoplasms*/surgery
Female ; Humans ; Neoplasm Staging ; Pregnancy ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer.
Autorzy :
Slørdahl KS; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Klotz D; Department of Pathology, Oslo University Hospital, Oslo, Norway.
Olsen JÅ; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Skovlund E; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Undseth C; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Abildgaard HL; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Brændengen M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
Nesbakken A; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway.
Larsen SG; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway.
Hanekamp BA; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Holmboe L; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Tvedt R; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Sveen A; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.; Department of Molecular Oncology, Oslo University Hospital, Oslo, Norway.
Lothe RA; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.; Department of Molecular Oncology, Oslo University Hospital, Oslo, Norway.
Malinen E; Department of Physics, University of Oslo, Oslo, Norway.; Department of Medical Physics, Oslo University Hospital, Oslo, Norway.
Kaasa S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Guren MG; Department of Oncology, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
Pokaż więcej
Źródło :
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Jul; Vol. 60 (7), pp. 921-930. Date of Electronic Publication: 2021 May 08.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Anus Neoplasms*/pathology
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/therapy
Chemoradiotherapy ; Humans ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Radical lymphadenectomy of a para-aorta lymph node metastasis in colorectal cancer prolongs relapse-free survival.
Autorzy :
Ichikawa Y; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Takahashi H; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan. .
Fujii M; Department of Mathematical Health Science, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Hata T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Ogino T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Miyoshi N; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Uemura M; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Yamamoto H; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Mizushima T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Doki Y; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Eguchi H; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Pokaż więcej
Źródło :
International journal of colorectal disease [Int J Colorectal Dis] 2021 Jul; Vol. 36 (7), pp. 1551-1560. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Journal Article
MeSH Terms :
Colorectal Neoplasms*/surgery
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/surgery
Aorta/surgery ; Female ; Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymph Nodes/surgery ; Lymphatic Metastasis ; Male ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Combination of aneuploidy and high S-phase fraction indicates increased risk of relapse in stage I endometrioid endometrial carcinoma.
Autorzy :
Patthey A; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Boman K; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
Tavelin B; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
Lindquist D; Department of Clinical Sciences, Umeå University, Umeå, Sweden.
Lundin E; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Hultdin M; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Pokaż więcej
Źródło :
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Sep; Vol. 60 (9), pp. 1218-1224. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
MeSH Terms :
DNA, Neoplasm*
Endometrial Neoplasms*/genetics
Aneuploidy ; Female ; Flow Cytometry ; Humans ; Neoplasm Recurrence, Local/genetics ; Prognosis ; S Phase
Czasopismo naukowe
Tytuł :
Outcomes of Tracheal Resections in Well-Differentiated Thyroid Cancer-A case series and meta-analysis.
Autorzy :
Warshavsky A; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel.
Rosen R; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel.
Nard-Carmel N; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel.
Muhanna N; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel.
Ungar O; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel.
Abergel A; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel.
Fliss DM; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel.
Horowitz G; The Department of Otolaryngology, Head & Neck Surgery and Maxillofacial Surgery, Tel-Aviv 'Sourasky' Medical Center, 'Sackler' School of Medicine, Tel-Aviv University, 6 Weizmann Street, 6423906, Tel-Aviv, Israel. .
Pokaż więcej
Źródło :
World journal of surgery [World J Surg] 2021 Sep; Vol. 45 (9), pp. 2752-2758. Date of Electronic Publication: 2021 May 22.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Neoplasm Recurrence, Local*
Thyroid Neoplasms*/surgery
Humans ; Neoplasm Invasiveness ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Differences in Radiomics Signatures Between Patients with Early and Advanced T-Stage Nasopharyngeal Carcinoma Facilitate Prognostication.
Autorzy :
Wu S; School of Physics, State Key Laboratory of Optoelectronic Materials and Technologies, Sun Yat-sen University, Guangzhou, PR China.
Li H; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, PR China.
Dong A; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, PR China.
Tian L; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, PR China.
Ruan G; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, PR China.
Liu L; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, PR China.
Shao Y; School of Physics, State Key Laboratory of Optoelectronic Materials and Technologies, Sun Yat-sen University, Guangzhou, PR China.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Sep; Vol. 54 (3), pp. 854-865. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Nasopharyngeal Neoplasms*/diagnostic imaging
Nasopharyngeal Neoplasms*/pathology
Neoplasm Recurrence, Local*
Humans ; Magnetic Resonance Imaging ; Nasopharyngeal Carcinoma/diagnostic imaging ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Management of squamous cell carcinoma of the temporal bone: long-term results and factors influencing outcomes.
Autorzy :
Piras G; Department of Otology and Skull Base Surgery, Gruppo Otologico and Mario Sanna Foundation, Via Emmanueli 42, 29121, Piacenza-Rome, Italy. .; Casa Di Cura 'Piacenza' S.P.A., Piacenza, Italy. .
Grinblat G; Hillel Yaffe Medical Center, Affiliated to Technion University, Haifa, Israel.
Albertini R; Department of Otolaryngology, Head and Neck Surgery, Bologna, Italy.; Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Sykopetrites V; Department of Otology and Skull Base Surgery, Gruppo Otologico and Mario Sanna Foundation, Via Emmanueli 42, 29121, Piacenza-Rome, Italy.; Casa Di Cura 'Piacenza' S.P.A., Piacenza, Italy.
Zhong SX; Department of Otolaryngology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Lauda L; Department of Otology and Skull Base Surgery, Gruppo Otologico and Mario Sanna Foundation, Via Emmanueli 42, 29121, Piacenza-Rome, Italy.; Casa Di Cura 'Piacenza' S.P.A., Piacenza, Italy.
Sanna M; Department of Otology and Skull Base Surgery, Gruppo Otologico and Mario Sanna Foundation, Via Emmanueli 42, 29121, Piacenza-Rome, Italy.; Casa Di Cura 'Piacenza' S.P.A., Piacenza, Italy.
Pokaż więcej
Źródło :
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2021 Sep; Vol. 278 (9), pp. 3193-3202. Date of Electronic Publication: 2020 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Squamous Cell*/pathology
Carcinoma, Squamous Cell*/surgery
Neoplasm Recurrence, Local*/pathology
Humans ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Survival Rate ; Temporal Bone/pathology ; Temporal Bone/surgery ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Autorzy :
Hada T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Miyamoto M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Ishibashi H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Matsuura H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Sakamoto T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Kakimoto S; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Iwahashi H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Suzuki R; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Sato K; Department of Pathology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Tsuda H; Department of Pathology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Takano M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Saitama, Tokorozawa, Japan.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Aug 13; Vol. 100 (32), pp. e26895.
Typ publikacji :
Journal Article
MeSH Terms :
Neoplasm Staging*
Adenocarcinoma, Mucinous/*pathology
Ovarian Neoplasms/*pathology
Biopsy ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; Progression-Free Survival ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies